NA-MFDS clash on the approval of abortion pills
By Lee, Jeong-Hwan | translator Alice Kang
24.10.14 05:50:12
가나다라
0
Reimbursement of the drugs ‘paused’ due to the non-revision of the Criminal Act, Mother and Child Health Act ‘
MFDS Minister Yu-Kyoung Oh, “lacks requirements for granting approval”
Rep In-soon Nam, “Don’t blame the law... we request a solid answer until the NA audit.”
With the National Assembly strongly pressing the need for domestic marketing authorization of the abortion drug ‘Mifegymiso,’ the NA’s request is set to affect the future administration of the MFDS’s marketing authorization review.
The MFDS has repeatedly argued that the Criminal Act and the Mother and Child Health Act must be amended before the drug receives marketing authorization, but the National Assembly responded that this is an unacceptable excuse and that the drug’s listing should not be delayed any longer.
On the 10th, Democratic Party of Korea lawmaker In-soon Nam made inquires to Yu-Kyoung Oh, the head of the Minister of Food and Drug Safety, that the government
Lee, Jeong-Hwan(junghwanss@dailypharm.com)
If you want to see the full article, please JOIN US (click)